Hepatitis B reactivation in people living with <scp>HIV</scp> and isolated anti‐ <scp>HBc</scp> receiving tenofovir‐sparing dual antiretroviral therapy

In this cross-sectional assessment, no evidence of HBV reactivation was detected in people living with HIV with isolated anti-HBc receiving TFV-sparing dual ART, including regimens without direct anti-HBV activity.